We are live on ! Find out more
PODD icon

Insulet

812 hedge funds and large institutions have $21.1B invested in Insulet in 2025 Q3 according to their latest regulatory filings, with 108 funds opening new positions, 339 increasing their positions, 243 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 243

32% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 82

2% more funds holding

Funds holding: 795812 (+17)

4% less capital invested

Capital invested by funds: $22B → $21.1B (-$935M)

2.6% less ownership

Funds ownership: 99.62%97.02% (-2.6%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

48% less call options, than puts

Call options by funds: $98.5M | Put options by funds: $191M

Holders
812
Holders Change
+17
Holders Change %
+2.14%
% of All Funds
10.66%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
108
Increased
339
Reduced
243
Closed
82
Calls
$98.5M
Puts
$191M
Net Calls
-$92.2M
Net Calls Change
+$24.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.72B +$27.5M +87,845 +1%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.34B +$19.8M +63,064 +0.8%
BlackRock
3
BlackRock
New York
$2.04B +$55.8M +178,194 +3%
Capital Research Global Investors
4
Capital Research Global Investors
California
$1.4B -$58.6M -187,058 -4%
State Street
5
State Street
Massachusetts
$954M +$10.6M +33,926 +1%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$646M -$13.6M -43,370 -2%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$604M +$11.9M +37,851 +2%
ClearBridge Investments
8
ClearBridge Investments
New York
$453M -$21.7M -69,390 -5%
American Century Companies
9
American Century Companies
Missouri
$434M +$30.4M +97,187 +7%
Invesco
10
Invesco
Georgia
$414M +$12.1M +38,584 +3%
Morgan Stanley
11
Morgan Stanley
New York
$392M +$3.46M +11,055 +0.9%
Fidelity International
12
Fidelity International
Bermuda
$343M -$5.98M -19,100 -2%
UBS AM
13
UBS AM
Illinois
$240M -$17.6M -56,028 -7%
Goldman Sachs
14
Goldman Sachs
New York
$234M -$72.4M -231,077 -23%
Northern Trust
15
Northern Trust
Illinois
$219M +$1.13M +3,618 +0.5%
Federated Hermes
16
Federated Hermes
Pennsylvania
$216M -$7.12M -22,739 -3%
Artisan Partners
17
Artisan Partners
Wisconsin
$206M -$823K -2,626 -0.4%
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$177M +$48.9M +156,009 +37%
Charles Schwab
19
Charles Schwab
California
$158M -$53M -169,074 -25%
Ameriprise
20
Ameriprise
Minnesota
$153M +$1.27M +4,057 +0.8%
Macquarie Group
21
Macquarie Group
Australia
$148M -$22.6M -72,119 -13%
Man Group
22
Man Group
United Kingdom
$143M +$24.2M +77,219 +20%
Bank of America
23
Bank of America
North Carolina
$142M -$29.2M -93,280 -17%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$126M +$1.53M +4,898 +1%
Nordea Investment Management
25
Nordea Investment Management
Sweden
$125M +$5.81M +18,553 +5%

PODD Hedge Fund Activity: Q3 2025 in Review

812 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2025, worth a combined $21.1B — down 4.2% from $22B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new PODD positions and 82 closed out — a net gain of 26 holders — while 339 added to existing stakes and 243 trimmed.

The largest buyer was Squarepoint, adding an estimated $70.6M. The largest seller was Citadel Advisors, cutting an estimated $131M.

  • 812 institutional investors held Insulet (PODD) as of Q3 2025, up from 795 in Q2 2025.
  • Funds reported $21.1B of Insulet stock for Q3 2025, down 4.2% quarter-over-quarter.
  • 108 funds opened new Insulet positions in Q3 2025 and 82 closed out, a net change of +26 holders.
  • The largest Insulet buyer in Q3 2025 was Squarepoint, an estimated $70.6M added.
  • The largest Insulet seller in Q3 2025 was Citadel Advisors, an estimated $131M sold.

Based on aggregated 13F filings for Q3 2025.